Compass Therapeutics, Inc. · NASDAQ:CMPX
BlackRock, Inc.'s stake in Compass Therapeutics, Inc. fell to 5.00% (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 4, 2025
BlackRock, Inc.'s stake in Compass Therapeutics, Inc. fell to 5.00%, 6,887,615 shares, as a passive investor on Dec 31, 2024. Filed Feb 4, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 6,887,615
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.00% | 6,887,615 |
Source
Related
- Compass Therapeutics, Inc.
- BlackRock, Inc.
- Compass Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 16, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026